in a pilot study , 21 consecutive and previously untreated adults with chronic granulocytic leukaemia received either busulphan ( group 1 : n = 11 ) or a combination of the epipodophyllotoxin vp16-213 with cytosine arabinoside and doxorubicin ( group 2 : n = 10 ) .
C0023473
chronic
C0006463
busulphan